Brief: Ars Pharmaceuticals Secures Up To $250 Million Loan Facility
29/09/2025 23:20
Sept 29 (Reuters) - ARS Pharmaceuticals Inc SPRY.O: ARS PHARMACEUTICALS SECURES UP TO $250 MILLION LOAN FACILITY WITH RA CAPITAL MANAGEMENT AND OMERS LIFE SCIENCES TO ACCELERATE U.S. COMMERCIALIZATION OF NEFFY® ARS PHARMACEUTICALS INC - ARS PHARMA BORROWS INITIAL $100 MILLION TO ACCELERATE NEFFY GROWTH Source text: ID:nGNXNb5gv Further company coverage: SPRY.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on ARS Pharmaceuticals
See all newsARS Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
ARS Pharmaceuticals Q2 neffy revenue rises as epinephrine market share doubles
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
ARS Pharma tumbles as allergy nasal spray faces insurance coverage hurdle